Katrina Vanura
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Changes in cardiac parameters during venetoclax treatment.
Journal: Haematologica
Published: January 15, 2025
Targeting sphingolipid metabolism in chronic lymphocytic leukemia.
Journal: Clinical and experimental medicine
Published: May 14, 2024
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.
Journal: Clinical and translational medicine
Published: May 11, 2023
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Journal: Cancer discovery
Published: April 26, 2021
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
Journal: Blood
Published: September 02, 2020
Reply to Comment on "UGT2B17 modifies drug response in chronic lymphocytic leukaemia".
Journal: British journal of cancer
Published: June 29, 2020
UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
Journal: British journal of cancer
Published: August 08, 2019
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.
Journal: Annals of hematology
Published: March 23, 2018
Last Updated: 09/26/2026